Beta -agonist, alpha1-agonist, and/or alpha2-antagonist treatment of neurodegenerative diseases and central nervous system trauma

摘要

The treatment of neurodegenerative diseases by the stimulation of endogenous or recombinant expression in vivo of nerve growth factor in the central nervous system by administration of a therapeutically effective amount of an (alpha)2-antagonist.